4//SEC Filing
Subramaniam Somu 4
Accession 0001415889-25-009374
CIK 0001851194other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:32 PM ET
Size
6.1 KB
Accession
0001415889-25-009374
Insider Transaction Report
Form 4
Subramaniam Somu
Director
Transactions
- Other
Common Stock
2025-03-28−1,335,450→ 4,032,213 total(indirect: See Footnote)
Footnotes (3)
- [F1]NSV Investments I, L.P. distributed shares to its limited partners on a pro rata basis, for no consideration.
- [F2]NSV Partners III, L.P. is the general partner of NSV Investments I, L.P. The reporting person is the majority member and managing member of NSV Partners III GP, LLC, which is the general partner of NSV Partners III, L.P., and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, L.P. is general partner. The reporting person is the majority member and managing member of NSV Partners II, LLC. The reporting person is the majority member and managing member of New Science Ventures, LLC. The reporting person disclaims beneficial ownership over the shares owned by each of the NSV Funds (as defined below), except to the extent of his pecuniary interest therein.
- [F3]The shares beneficially owned by the reporting person consists of: (i) 1,807,664 shares owned by NSV Investments I, L.P., (ii) 1,381,606 shares owned by NSV Partners III, L.P., (iii) 434,423 shares owned by New Science Ventures, LLC, and (iv) 408,520 shares owned by NSV Partners II, LLC (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001508910
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:32 PM ET
- Size
- 6.1 KB